The FDA approved Kerendia in July 2021 for adults with chronic kidney disease associated with Type 2 diabetes to reduce the risk of kidney function decline, kidney failure and cardiovascular events, ...

the hazard ratio of a first recurrence of any atrial tachyarrhythmia -- atrial fibrillation, flutter, or tachycardia -- lasting at least 30 seconds during the period from day 91 to day 365 after ...

Parkinson disease (PD) is associated with a greater prevalence of arrhythmias among hospitalized adults and may increase the risk for mortality, according to study results presented at the American ...

The study concluded that treatment with SGLT-2I in conjunction with GLP-1RA may help to reduce the incidence of AF/flutter ...

Uncover why 5 silent heart conditions are surging in families in 2025, from genes to stress, and how to spot them early.

Researchers have discovered in a study published in JAMA Cardiology that finerenone offers stable benefits in heart failure ...

Methods Patients who were admitted for a day-case elective DC cardioversion for atrial fibrillation or atrial flutter were asked to participate in the study. DC cardioversion was performed using the ...

In trials that included patients with atrial fibrillation, atrial flutter or other supraventricular arrhythmia, only the subset of patients with atrial fibrillation was included if the data were ...